NHS Framework Agreement for the supply of Icatibant & C1 Esterase products for the treatment of Hereditary Angioedema
Icatibant, C1 Esterase products for the treatment of Hereditary Angioedema
Buyer
NHS ENGLAND
Value
£15,000,000
Published
2 Nov 2021
Closes
2 Nov 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS Framework Agreement for the supply of Icatibant & C1 Esterase products for the treatment of Hereditary Angioedema
£15,000,000
Icatibant, C1 Esterase products for the treatment of Hereditary Angioedema
Delivery: British Oversea Territories, Channel Islands, England · United Kingdom, Europe, Guernsey, Isle of Man
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
13 Dec 2019
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Future opportunity notice on Contracts Finder
2 Nov 2021
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.